Latest Videos

{{ currentStream.Name }}

Related Video

Continuous Play:
ON OFF

The information you requested is not available at this time, please check back again soon.

More Video

Jan 12, 2021

Pfizer drops after CEO forecasts profit lower than analyst view

Ross Healy discusses Pfizer

VIDEO SIGN OUT

Security Not Found

The stock symbol {{StockChart.Ric}} does not exist

See Full Stock Page »

Pfizer Inc. shares fell after Chief Executive Officer Albert Bourla said 2021 adjusted earnings would be between US$3 and US$3.10 per share, less than what analysts were expecting.

The shares dropped 1.7 per cent to US$37.13 at 10:38 a.m. in New York trading. Analysts had expected adjusted earnings per share in 2021 of US$3.18, according to a survey of 16 analysts by Bloomberg.

Bourla previewed the company’s earnings guidance while speaking at the JPMorgan Healthcare Conference on Tuesday. He said the number included the likely contribution from the COVID-19 shot that was the first vaccine authorized for emergency use in the U.S.

The company developed the vaccine in partnership with Germany’s BioNTech SE.